APA (7th ed.) Citation

Siddiqi, Z. A., Nowak, R. J., Mozaffar, T., O'Brien, F., Yountz, M., Patti, F., . . . Mercelis, R. (2021). Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: Subgroup analysis of REGAIN and its extension study. Muscle & Nerve, 64(6), 662. https://doi.org/10.1002/mus.27422

Chicago Style (17th ed.) Citation

Siddiqi, Zaeem A., et al. "Eculizumab in Refractory Generalized Myasthenia Gravis Previously Treated with Rituximab: Subgroup Analysis of REGAIN and Its Extension Study." Muscle & Nerve 64, no. 6 (2021): 662. https://doi.org/10.1002/mus.27422.

MLA (9th ed.) Citation

Siddiqi, Zaeem A., et al. "Eculizumab in Refractory Generalized Myasthenia Gravis Previously Treated with Rituximab: Subgroup Analysis of REGAIN and Its Extension Study." Muscle & Nerve, vol. 64, no. 6, 2021, p. 662, https://doi.org/10.1002/mus.27422.